Hypogammaglobulinemia
📧 Sign up to get email alerts when something new happens for Hypogammaglobulinemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy, safety, and pharmacokinetics of XEMBIFY plus standard medical treatment (SMT) versus pl…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia [Phase 2]
Phase 2 clinical trial investigating IgPro20 to prevent infections in people with multiple myeloma and hypogammaglobulinemia. The study is c…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections [Phase 3]
Phase 3 trial update evaluating Panzyga to prevent infections in patients with hypogammaglobulinemia receiving autoimmune therapy. The study…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study) [Phase 3]
A Phase III study (PRO-SID) evaluating Panzyga for primary infection prophylaxis in patients with chronic lymphocytic leukemia and hypogamma…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: COVID-19 Vaccine Responses in PIDD Subjects
This clinical trial update describes COVID-19 vaccine responses in patients with primary immunodeficiency diseases (PIDD), including X-linke…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
A clinical trial is assessing whether immunoglobulin replacement can address fatigue in patients with Multiple Sclerosis who have hypogammag…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating antibiotic therapy or immunoglobulin strategies in patients with hematologic malignancies and hy…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia) [Phase 2]
Phase 2 clinical trial update evaluating a 10% triple virally reduced intravenous immunoglobulin in patients with primary immunodeficiency (…
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) [Phase 3]
A Phase 3 study evaluating Kedrion IVIG 10% for efficacy and safety in subjects with primary immunodeficiency shows completed status with re…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Intravenous Immunoglobulin (IVIG) in Lung Transplantation [Phase 2]
A Phase 2 clinical trial evaluating intravenous immunoglobulin (IVIG) in patients undergoing lung transplantation has been completed, with r…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Post-bypass Prophylactic IVIG in Infants and Neonates [NA]
This clinical trial update reports the results of a completed study evaluating post-bypass prophylactic intravenous immunoglobulin (IVIG) in…
-
CLINICAL_TRIALS research · 2017-04-04Clinical Trial Update: Investigation of Immune Disorders and Deficiencies
Clinical trial update from O & O Alpan LLC investigating immune disorders and deficiencies; conditions include primary immune deficiencies, …
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency [Phase 2]
The document reports the completion of a Phase 2 trial of PNEUMOCELL, a conjugated pneumococcal vaccine, in patients with IgG deficiency.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) [Phase 3]
Phase 3 trial results show safety and efficacy of CSL Behring's intravenous immunoglobulin IgPro10 in patients with primary immunodeficienci…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) [Phase 3]
Phase 3 trial reports on efficacy and safety of IgPro10 (intravenous immunoglobulin) for primary immunodeficiencies; study completed in agam…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of IVIG-F10 in primary immunodeficiencies has completed, covering agammaglobulinemia, hypog…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating Cytomegalovirus hyperimmune globulin (CMV-Ig) replacement in hypogammaglobulinemic lung transplant recipien…
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. [Phase 3]
Phase 3 study evaluating the efficacy, safety, and pharmacokinetics of Gammaplex in primary immunodeficiency diseases completed with results…
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients [Phase 2, Phase 3]
A completed Phase 2/3 trial update examining the kinetics, efficacy, and safety of IVIG-L in patients with hypogammaglobulinemia.